Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic HBV Infection (HBeAg Negative)”

96 trials

Showing 20 of 96 results

Post-approval studies (Phase 4)Study completedNCT00354653
What this trial is testing

A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone

Who this might be right for
CHRONIC HEPATITIS B
ViiV Healthcare 100
Not applicableStudy completedNCT00263614
What this trial is testing

Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases.

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 100
Testing effectiveness (Phase 2)Study completedNCT03905655
What this trial is testing

Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Romark Laboratories L.C. 51
Post-approval studies (Phase 4)UnknownNCT02745704
What this trial is testing

The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg

Who this might be right for
Chronic Hepatitis B
Third Affiliated Hospital, Sun Yat-Sen University 200
Not applicableStudy completedNCT05451420
What this trial is testing

Inactive HBsAg Carriers (IHCs) Treated With Pegylated Interferon α2b Based Intervention Therapy

Who this might be right for
Chronic Hepatitis B
Henan Provincial People's Hospital 33
Testing effectiveness (Phase 2)UnknownNCT04568265
What this trial is testing

A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B

Who this might be right for
Hepatitis BChronic Hep BHBV
Ascentage Pharma Group Inc. 122
Testing effectiveness (Phase 2)Study completedNCT02565719
What this trial is testing

REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection

Who this might be right for
Chronic Hepatitis B
Replicor Inc. 40
Post-approval studies (Phase 4)Study completedNCT01379508
What this trial is testing

Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

Who this might be right for
Chronic Hepatitis B
Novartis Pharmaceuticals 241
Not applicableStudy completedNCT01730508
What this trial is testing

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 978
Not applicableUnknownNCT01243281
What this trial is testing

Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Chulalongkorn University 126
Large-scale testing (Phase 3)Study completedNCT00117676
What this trial is testing

Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 382
Not applicableStudy completedNCT01667432
What this trial is testing

An Observational Study of Peginterferon Alfa-2a (PEGASYS®) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 141
Testing effectiveness (Phase 2)Active Not RecruitingNCT06550128
What this trial is testing

Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB).

Who this might be right for
Hepatitis B, Chronic
Ausper Biopharma Co., Ltd. 86
Post-approval studies (Phase 4)Study completedNCT00436163
What this trial is testing

Peginterferon Alfa-2a (40KD) (PEGASYS®) in Participants With Hepatitis B Envelope Antigen (HBeAg) - Positive Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 39
Not applicableWithdrawnNCT01260610
What this trial is testing

Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis B
Institute of Liver and Biliary Sciences, India
Testing effectiveness (Phase 2)Study completedNCT02233075
What this trial is testing

REP 2139-Ca / Pegasys™ Combination Therapy in Hepatitis B / Hepatitis D Co-infection

Who this might be right for
Chronic HBV Infection (HBeAg Negative)
Replicor Inc. 12
Testing effectiveness (Phase 2)UnknownNCT01027065
What this trial is testing

Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients

Who this might be right for
Chronic Hepatitis B
Cytheris SA 24
Testing effectiveness (Phase 2)Study completedNCT02881008
What this trial is testing

Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Hepatera Ltd. 48
Post-approval studies (Phase 4)Ended earlyNCT00460850
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 60
Testing effectiveness (Phase 2)Looking for participantsNCT06963710
What this trial is testing

A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)

Who this might be right for
Chronic Hepatitis B Infection
Aligos Therapeutics 200
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation